Positive pre-biopsy MRI: are systematic biopsies still useful in addition to targeted biopsies?

Détails

ID Serval
serval:BIB_56C9ABE1591F
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
Positive pre-biopsy MRI: are systematic biopsies still useful in addition to targeted biopsies?
Périodique
World journal of urology
Auteur⸱e⸱s
Ploussard G., Borgmann H., Briganti A., de Visschere P., Fütterer J.J., Gandaglia G., Heidegger I., Kretschmer A., Mathieu R., Ost P., Sooriakumaran P., Surcel C., Tilki D., Tsaur I., Valerio M., van den Bergh R.
Collaborateur⸱rice⸱s
EAU-YAU Prostate Cancer Working Group
ISSN
1433-8726 (Electronic)
ISSN-L
0724-4983
Statut éditorial
Publié
Date de publication
02/2019
Peer-reviewed
Oui
Volume
37
Numéro
2
Pages
243-251
Langue
anglais
Notes
Publication types: Journal Article ; Review
Publication Status: ppublish
Résumé
The diagnostic strategy implementing multiparametric magnet resonance tomography (mpMRI) and targeted biopsies (TB) improves the detection and characterization of significant prostate cancer (PCa). We aimed to assess the clinical usefulness of systematic biopsies (SB) in the setting of patients having a pre-biopsy positive MRI.
A review of the literature was performed in March 2018. All studies investigating the performance of SB in addition to TB (all techniques) were assessed, both in the biopsy-naïve and repeat biopsy setting.
Evidence demonstrates that TB improves the detection of index-significant PCa compared with SB alone, in both initial and repeat biopsy settings. However, the combination of both TB and SB improved the overall (around 30%) and significant (around 10%) PCa detection rates as compared with TB alone. Significant differences between both biopsy approaches exist regarding cancer location favoring SB for the far lateral sampling, and TB for the anterior zone. Main current pitfalls of pure TB strategy are the learning curve and experience required for mpMRI reading and biopsy targeting, as well as the precision assessment in TB techniques.
A pure TB strategy omitting SB leads to the risk of missing up to 15% of significant cancer, due to limitations of mpMRI performance/reading and of precision during lesion targeting. SB remain necessary, in addition to the TB, to obtain the most accurate assessment of the entire prostate gland in this sub-group of patients at risk of significant disease.
Mots-clé
Biopsy/methods, Humans, Image-Guided Biopsy, Magnetic Resonance Imaging, Magnetic Resonance Imaging, Interventional, Male, Prostate/pathology, Prostatic Neoplasms/pathology, Biopsy, Detection, Fusion, Magnetic resonance imaging, Prostate cancer, Targeted
Pubmed
Web of science
Création de la notice
18/07/2018 16:05
Dernière modification de la notice
20/08/2019 14:11
Données d'usage